Skip to main content
. 2014 May 21;21(1):50. doi: 10.1186/1423-0127-21-50

Table 2.

Virus titers (TCID 50 */50 μl) 48 h post infection without or in presence of anti-CAR (RmcB), anti-DAF (BRIC 216), or both

Isolate Control (No Ab) +BRIC216 + RcmB RcmB + BRIC216
Nancy
 107.5
 103
 103
 102.5
Rec (B3/B4)
 108
 104
 103.7
 102
B3-37335
 107.3
 107
 103
 102
B3-523-21
 107.3
 103.6
 103.5
 102
B3-02
 106.6
 103.9
 103.3
 102
B4N
 107
 107
 104
 102
B4-37428
 106.6
 106
 103.3
 103
B4 JVB
 107.3
 107
 104
 102.7
B4-0612
 105.3
 105
 103.7
 102
B4-07
 105.3
 105
 103.5
 102
B5-37534
 107
 103
 103
 102
B5-2003
 108
 104.9
 103
 102
B5-99
 106.33
 106
 103
 102
B5-2000
 107.3
 107
 104
 102
B6-041
 105.9
 105
 103.5
 102
B2-37222
 106.3
 106
 104
 102.5
B2N
 106
 106
 103.5
 102.5
B2-0610 M
 105.3
 105
 103
 102
B2-2000
 106.3
 106
 104
 102.7
B1-032
 107.6
 103.9
 103
 103
B1-0609
 106.3
 106
 103
 102
B1-0807 107.6 104 103 102

(*) TCID50: 50% Tissue Culture Infective Dose.

Ab: antibodies.